Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. 2010

Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
Department of Dermatology and Allergology, Ruhr-University Bochum, Bochum, Germany. michael.sand@ruhr-uni-bochum.de

BACKGROUND Dysregulation of microRNA (miRNA) metabolism has been observed in a variety of human cancers. In this pilot study, we investigated expression profiles of the two most important enzymes of the miRNA machinery, Drosha and Dicer, in relation to epithelial skin cancer and its premalignant stage. METHODS Patients with premalignant actinic keratoses (AK, n = 6), basal cell carcinomas (BCC, n = 15), and squamous cell carcinomas (SCC, n = 7) were included in the study. Punch biopsies were harvested from the center of the tumors (lesional) as well as from sites of healthy skin (intraindividual controls). Skin samples (n = 14) were also obtained from healthy subjects for additional controls. Dicer and Drosha mRNA levels were detected by quantitative real-time reverse transcriptase polymerase chain reaction. RESULTS Drosha expression levels were significantly upregulated in both the BCC and SCC groups compared to those in the healthy controls (p < .01), while Dicer expression levels in the BCC group were significantly lower (p < .05). Dicer expression in the SCC group was significantly higher compared to intraindividual controls (p < .05), while Dicer expression levels in both the SCC and AK groups were not significantly different from healthy control samples (p > .05). In the premalignant AK group, we could not observe any significant difference in Drosha or Dicer expression levels compared to either healthy or intraindividual controls (p > .05). CONCLUSIONS We observed dysregulation of Drosha and Dicer expression in epithelial tumors when compared to healthy control samples. Therefore, we favor the hypothesis that miRNAs are involved in the carcinogenesis of epithelial skin cancer.

UI MeSH Term Description Entries
D008297 Male Males
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
February 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
January 2012, Journal of cancer research and clinical oncology,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
October 2013, Open biology,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
January 2021, Frontiers in molecular biosciences,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
November 2010, Nucleic acids research,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
September 2018, FEBS letters,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
June 2019, Biochemical and biophysical research communications,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
July 2007, Circulation research,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
April 2012, Pathology oncology research : POR,
Michael Sand, and Thilo Gambichler, and Marina Skrygan, and Daniel Sand, and Nina Scola, and Peter Altmeyer, and Falk G Bechara
January 2013, International journal of clinical and experimental medicine,
Copied contents to your clipboard!